BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20937296)

  • 1. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
    Jiang A; Gao H; Kelley MR; Qiao X
    Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.
    Sardar Pasha SPB; Sishtla K; Sulaiman RS; Park B; Shetty T; Shah F; Fishel ML; Wikel JH; Kelley MR; Corson TW
    J Pharmacol Exp Ther; 2018 Oct; 367(1):108-118. PubMed ID: 30076264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.
    Li Y; Liu X; Zhou T; Kelley MR; Edwards PA; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4461-9. PubMed ID: 24970265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
    Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
    Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis.
    Jiang A; Hu W; Meng H; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):844-50. PubMed ID: 18936153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
    Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
    Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
    Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
    Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
    Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
    Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
    PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.
    Fishel ML; Colvin ES; Luo M; Kelley MR; Robertson KA
    Exp Hematol; 2010 Dec; 38(12):1178-88. PubMed ID: 20826193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
    Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.
    Kelley MR; Georgiadis MM; Fishel ML
    Curr Mol Pharmacol; 2012 Jan; 5(1):36-53. PubMed ID: 22122463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
    Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
    Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.
    Luo M; Delaplane S; Jiang A; Reed A; He Y; Fishel M; Nyland RL; Borch RF; Qiao X; Georgiadis MM; Kelley MR
    Antioxid Redox Signal; 2008 Nov; 10(11):1853-67. PubMed ID: 18627350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APE1/Ref-1 as a Novel Target for Retinal Diseases.
    Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
    J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
    Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
    Zou GM; Maitra A
    Mol Cancer Ther; 2008 Jul; 7(7):2012-21. PubMed ID: 18645011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
    Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
    J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.
    Akhter N; Takeda Y; Nara H; Araki A; Ishii N; Asao N; Asao H
    J Biol Chem; 2016 Nov; 291(45):23672-23680. PubMed ID: 27637330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
    Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
    J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.